134
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?

ORCID Icon, , , , , ORCID Icon, & show all

References

  • Ali RH, Rouzbahman M. 2015. Endometrial stromal tumors revisited: an update based on the 2014 WHO classification. Journal of Clinical Pathology 68:325–332.
  • Amant F, De Knijf A, Van Calster B, Leunen K, Neven P, Berteloot P, et al. 2007. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. British Journal of Cancer 97:1194–1199.
  • Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, et al. 2014. Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 24:S67–S72.
  • Barney B, Tward JD, Skidmore T, Gaffney DK. 2009. Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma? International Journal of Gynecologic Cancer 19:1232–1238.
  • Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, et al. 2001. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecologic Oncology 81:160–165.
  • Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. 1990. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. The American Journal of Surgical Pathology 14:415–438.
  • Deshmukh U, Black J, Perez-Irizarry J, Passarelli R, Levy K, Rostkowski A, et al. 2019. Adjuvant hormonal therapy for low-grade endometrial stromal sarcoma. Reproductive Sciences 26:600–608.
  • ESMO. 2014. European Sarcoma Network Working Group Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 25:iii102–iii112.
  • Hosh M, Antar S, Nazzal A, Warda M, Gibreel A, Refky B. 2016. Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database. International Journal of Gynecologic Cancer 26:1098–1104.
  • Koh W-J, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. 2015. Uterine sarcoma, version 1.2016. Journal of the National Comprehensive Cancer Network 13:1321–1331.
  • Li AJ, Giuntoli RL, Drake R, Byun SY, Rojas F, Barbuto D, et al. 2005. Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstetrics & Gynecology 106:1304–1308.
  • Li N, Wu L-Y, Zhang H-T, An J-S, Li X-G, Ma S-K. 2008. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases. Gynecologic Oncology 108:306–311.
  • Nasioudis D, Ko EM, Kolovos G, Vagios S, Kalliouris D, Giuntoli RL. 2019. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 29:126–132.
  • Prat J. 2009. FIGO staging for uterine sarcomas. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 104:177–178.
  • Reed N, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, et al. 2008. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). European Journal of Cancer 44:808–818.
  • Riopel J, Plante M, Renaud M-C, Roy M, Tetu B. 2005. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecologic Oncology 96:402–406.
  • Stewart L, Beck T, Giannakopoulos N, Rendi M, Isacson C, Goff B. 2018. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: a multicenter review. Gynecologic Oncology 149:297–300.
  • Thiel FC, Halmen S. 2018. Low-grade endometrial stromal Sarcoma – a Review. Oncology Research and Treatment 41:687–692.
  • Yoon A, Park J-Y, Park J-Y, Lee Y-Y, Kim T-J, Choi CH, et al. 2014. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases. Gynecologic Oncology 132:70–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.